[1] |
WU Ye, LIU Xiao-di, XU Yan-ni, LUO Bao-ming.
Methionine deficiency increase the drug sensitivity of regorafenibfor hepatocellular carcinoma cells
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 24-29.
|
[2] |
HUANG Zhan-ren, NING Jin-yue, LI Han-qin, CHEN Nian-ping.
Advances of the conversion therapy of immune checkpoint inhibitors combined antiangiogenic targeted drugs for advanced hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 110-114.
|
[3] |
SONG Yan-zhou, KANG Zhi-long, SU Yi-nan, ZHANG Yi-ming, ZHAO Xin, LI Zhi-wei, LI Wei.
Expression of NEK7 in patients with primary hepatocellular carcinoma and its clinical significance
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 608-613.
|
[4] |
MA Xiao-wu, TAN Wen-liang, YANG Lei, XIE Zhi-qin, WANG Qing-bin, CHEN Ya-jin, SHANG Chang-zhen.
Experimental study of circKDM4B on the proliferation, migration and invasion of hepatocellular carcinoma cells
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 614-619.
|
[5] |
LU Xu, LI Hua, YI Shu-hong, ZHAO Hui, ZHU Shu-guang, LI Hai-bo, YANG Yang, WANG Guo-ying.
Transarterial chemoembolization combined with Lenvatinib bridging in the treatment of 2 patients with hepatocellular carcinoma exceeding Milan standard liver transplantation
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(05): 507-511.
|
[6] |
WU Juan-hua, TAN Hui-min, ZUO Chao-hai, KUANG Nai-le, YU Jie-xiong, CHEN Yun-yang..
Analysis of TACE on prevention of postoperative recurrence in patient with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 397-404.
|
[7] |
SU Ru-ping, LI Ni, ZHONG Li, ZHAO Zhi.
Laparoscopic hepatectomy and splenic artery ligation in surgical treatment for cirrhotic patients with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 415-418.
|
[8] |
WANG Dao-du, ZHAO Qi-jiong, ZHOU Zhi-biao, HE Yong-yue.
Development of the prognosis signature for hepatocellular carcinoma based on ferroptosis-related genes
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 419-424.
|
[9] |
WANG Qing-bin, SHANG Chang-zhen, CHEN Ya-jin.
Progress on the prognosis prediction of hepatocellular carcinoma after liver resection
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 471-476.
|
[10] |
DING Chen-chen, SONG Xing-dong, ZHANG Lei.
2021 ASCO in the vision of liver surgeons
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 265-271.
|
[11] |
WU Jun-hua, CHEN Yun-yang, ZHANG Xin, YU Jie-xiong, CUI En-ming, ZHANG Hui-ling.
Expression and clinical value of RNF24 in patients with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 165-170.
|
[12] |
HU Zhi-peng, SUN Qiang, HU Ze-min, CHEN Wei-qiang.
Advances in the selection of therapeutic modalities for BCLC stage-B hepatocellular carcinoma based on enhanced CT radiomics model
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 233-238.
|
[13] |
HUO Li-yun, WEI Ying-cheng, TAN Wen-liang, SHANG Chang-zhen, CHEN Ya-jin.
The clinical significance of SMC gene family in the diagnosis and prognosis of hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 24-28.
|
[14] |
HUANG Yi-pei, LUO Wei-xin, XU Lei-bo.
Expression and function of transcription factor YY1 in hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 44-52.
|
[15] |
CHEN Jingsen, OU Xi, ZHAO Yang, YU Guangyin, LIU Xiaoping.
Distribution characteristics of LAP+CD4+T cells in the tumor microenvironment of hepatocellular carcinoma and its significance
[J]. Lingnan Modern Clinics in Surgery, 2019, 19(05): 528-532.
|